Vadodara, India

Rutvij Manharlal Bhatt

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rutvij Manharlal Bhatt. Retrieved from https://idiyas.com/inventor/rutvij-manharlal-bhatt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rutvij Manharlal Bhatt: Pharmaceutical Process Inventor

Introduction

Rutvij Manharlal Bhatt is an inventor associated with Vadodara, India, and Sun Pharmaceutical Industries Limited. His patent work concerns a process for preparing chiral beta amino carboxamide derivatives.

Latest Patents

Bhatt is named on 1 patent: “Process for the Preparation of Chiral Beta Amino Carboxamide Derivatives.” The invention describes selectively preparing a compound in either the R-configuration or the S-configuration, or a pharmaceutically acceptable salt, while favoring the chosen configuration over the other enantiomer.

Career Highlights

Bhatt’s listed invention focuses on stereoselective preparation of pharmaceutical compounds, an area relevant to developing and manufacturing medicines. He is associated with Sun Pharmaceutical Industries Limited.

Collaborations

The listed coworkers associated with Bhatt include Rajamannar Thennati and Trinadha Rao Chitturi.

Conclusion

Rutvij Manharlal Bhatt’s patent record highlights his contribution to pharmaceutical process innovation through a method for selectively preparing chiral beta amino carboxamide derivatives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…